|
⚲
|
| Keyboard |
| Redmile Biopharma Investments II LP
✚
|
|
|---|---|
| CIK # | 0001772230 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001772230] | |
| 4 | [0001772230] | |
| D | [0001772230] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Redmile Group LLC | |
| Green Jeremy | |
| Redmile Biopharma Investments II LP | |
| RayzeBio Inc | |
| Absci Corp |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
RayzeBio Inc RYZB
Common Stock
|
2023-09-19 | Conversion | 494,687 | ||
|
RayzeBio Inc RYZB
Common Stock
|
2023-09-19 | Conversion | 498,510 | ||
|
RayzeBio Inc RYZB
Common Stock
|
2023-09-19 | Conversion | 864,509 | ||
|
RayzeBio Inc RYZB
Series C Preferred Stock · derivative
|
2023-09-19 | Conversion | 432,254 | $0.00 | |
|
RayzeBio Inc RYZB
Series D Preferred Stock · derivative
|
2023-09-19 | Conversion | 498,510 | $0.00 | |
|
RayzeBio Inc RYZB
Series B Preferred Stock · derivative
|
2023-09-19 | Conversion | 864,509 | $0.00 |